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Abstract 
fMRI Neurofeedback research employs many different control conditions. Currently, 
there is no consensus as to which control condition is best, and the answer depends on what 
aspects of the neurofeedback-training design one is trying to control for. These aspects can 
range from determining whether participants can learn to control brain activity via 
neurofeedback to determining whether there are clinically significant effects of the 
neurofeedback intervention. Lack of consensus over criteria for control conditions has 
hampered the design and interpretation of studies employing neurofeedback protocols. This 
paper presents an overview of the most commonly employed control conditions currently used 
in neurofeedback studies and discusses their advantages and disadvantages. Control 
conditions covered include no control, treatment-as-usual, bidirectional-regulation control, 
feedback of an alternative brain signal, sham feedback, and mental-rehearsal control. We 
conclude that the selection of the control condition(s) should be determined by the specific 
research goal of the study and best procedures that effectively control for relevant confounding 
factors.  
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1. Introduction 
Neurofeedback is increasingly coming into the focus of translational neuroscience 
research, both as a tool for understanding brain-behavior relationships and as a potential 
intervention for a variety of neurological and psychiatric diseases. A PubMed search of the term 
“neurofeedback” reveals that compared to 10 years ago the number of journal papers published 
on the topic has increased by 850%. Neurofeedback can be employed using brain 
hemodynamics (as with functional magnetic resonance imaging [fMRI] or functional near-
infrared spectroscopy [fNIRS]) as well as neuroelectric signals (as with electroencephalography 
[EEG], magnetoencephalography [MEG], or intracortical recordings). In this paper, we focus on 
fMRI neurofeedback, though many of our conclusions can be applied to other feedback 
methods, such as EEG. Neurofeedback contains several interacting features including the 
modification of brain activity during the procedure, the psychological processes involved in the 
self-regulation training, the instructions provided by the researcher, the high-tech environment, 
and the patients’ expectancies associated with it. In a clinical context neurofeedback can thus 
be conceptualized as a complex intervention (1).  Specific guidance is available for the 
development, outcome and process evaluation of complex interventions (1, 2), which should be 
considered when designing neurofeedback trials. Careful documentation of the components of 
the intervention is an important part of the design, and the real time fMRI-neurofeedback 
community is working towards this documentation, as evidenced by a recent survey employing 
the Template for Intervention Description and Replication (TIDieR) checklist (3). Furthermore, 
neurofeedback researchers are encouraged to pre-register experiments and standardize 
measures, designs, statistical analysis, and reporting(4).  
The stage of development of the intervention and the specific research focus – for 
example, assessment of feasibility, evaluation of efficacy or effectiveness – will determine 
whether randomized or non-randomized designs are more applicable, and in randomized 
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designs, the choice of appropriate control conditions. Because neurofeedback is a complex 
intervention, there are numerous factors that must be considered and should be controlled for in 
order for causality to be unambiguously established. These factors include (Table 1): 
 Participant Motivation/Perception of Success: Are participants actively trying to 
change their brain activity? Are differences in behavioral, clinical or brain changes 
across groups driven by differences in motivation/self-efficacy? This includes 
controlling for reward, frustration, and suspicion of control-group assignment.  
 Neurophysiological Specificity: Is feedback from the target region required to obtain 
the desired changes in activity within that region or behavior to occur? Would simply 
gaining control (or perceiving to gain control) over brain activity more generally also 
result in these changes?   
 Placebo/Expectation Effects/Participant Bias: What proportion of the 
behavioral/clinical effects is due to the use of a high-tech ‘train-your-brain’ 
environment that participants believe to be effective?  
 Non-Specific Effects: What proportion of the obtained activity/behavior/clinical 
change is caused by more general factors? These factors may include arousal, 
perceptual input, and physiological parameters such as breathing and heart rate. 
Would simply changing breathing or arousal levels result in the same brain and 
behavioral/clinical changes?  
 Behavioral Effects: Would practicing a specific mental strategy to control brain 
activity in the absence of neurofeedback result in the same neural and 
behavioral/clinical changes? Is the neurofeedback component crucial in this context?  
In this paper, we review the most commonly employed control conditions currently with a focus 
on which factors are (and are not) controlled for in each condition. These control conditions 
include (Figure 1): 
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 No Control: No control condition is included; only within-subject changes are examined.  
 No-Training Control: Participants do not receive any additional training. In clinical 
studies, this might include treatment-as-usual (TAU) or a waitlist control group.  
 Bidirectional-Regulation Control: Participants are trained to self-regulate brain activity in 
opposite directions, or to self-regulate different aspects of brain function that induce the 
opposite behavioral changes.  
 Placebo Control: Participants are provided with an alternative feedback signal.  
o Neurofeedback of Alternative Brain Signal: Participants are provided with 
feedback of an alternative aspect of brain function. For example, in studies where 
the experimental group is trained to control activity in a specific brain region, the 
control group may be trained to modulate activity in a different brain region.  
o Non-Neural Feedback: Participants are provided with feedback based on non-
brain signals. These signals can include various physiological measures such as 
breathing, heart rate, or skin conductance.  
o Sham Feedback: Participants are not provided with their own feedback signal. 
Instead a signal of another participant (‘yoked feedback’) or an artificially 
generated signal is presented.  
 Mental-Rehearsal Control: In the absence of any feedback information, participants 
engage in the same mental strategy that is used by participants in the experimental 
group, or a strategy that is known to be related to the trained brain signal.   
2 When is No Control Acceptable? 
Early phases of development and evaluation of a novel medical intervention may occur 
without direct clinical testing or implementation of control conditions. Both the US 
(https://wwwnimhnihgov/about/directors/thomas-insel/blog/2012/experimental-
medicineshtml2012) and the UK medical funding organizations 
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(https://www.mrc.ac.uk/documents/pdf/rcts-for-complex-interventions-to-improve-health/) have 
provided guidelines for phased development and evaluation of complex interventions. In the 
case of neurofeedback, the “preclinical” or “theoretical” phase may entail the identification of 
target brain signals or states based on meta-analyses of published functional neuroimaging 
studies, the programming/development of the appropriate experimental protocols/brain-
computer interfaces (BCIs) and the testing of the setup in healthy individuals. The “modelling” 
phase can involve experimental brain-imaging studies and comparison of different 
neurofeedback protocols in healthy participants or patients, but also exclusively rely on 
modelled data obtained from simulations. It has recently been shown that simulation studies can 
be useful for the assessment of feasibility of real-time fMRI neurofeedback protocols (5). The 
next stage would be an “exploratory trial”, which could employ an adaptive design, in order to 
optimize the intervention and assess its feasibility in the targeted patient population. Parameters 
of feasibility would include the ability of patients to attain the desired level of control of the 
targeted measure of brain activity (e.g., up- or downregulation of the mean hemodynamic signal 
across a brain region or network, up- or downregulation of a parameter of functional 
connectivity, or increasing similarity of a brain-activity pattern to a template identified by 
machine learning), patient adherence more generally (e.g., assessed by debriefing), 
determination of dosing (number of sessions required for a change in brain and/or behavior to 
occur), patient retention, and patient satisfaction. The fidelity of treatment delivery by the 
research team or therapists is also an important consideration when designing reliable 
intervention protocols (6). This approach is similar to Phase I Clinical Trial designs which aim 
only to determine the safety and feasibility of the novel treatment/procedure (7). No control 
group is required to address these questions, and a single-group design would thus normally be 
appropriate at this stage.   
In single-group designs, while repeated measures are used, non-specific effects 
(including placebo, motivation, and simple practice effects) cannot be ruled out. For studies 
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examining changes in symptoms over time, particularly those examining psychiatric symptoms, 
regression towards the mean and natural recovery are particularly problematic without an 
appropriate control (8). In other (particularly chronic and progressive) disorders, such as 
Parkinson’s disease where spontaneous remission is not observed, within-subject changes can 
indeed allow for some conclusions to be drawn regarding the efficacy of the intervention, but 
placebo effects cannot be excluded.  
Many fMRI-neurofeedback studies that have not included control conditions have been 
labeled as “pilot,” “feasibility,” or “preliminary” studies in the title (9-12). Studies lacking a control 
condition can be cost-effective for making decisions about whether to continue with the 
particular line of research. It is particularly important in single-group designs to examine 
differences in outcome/behavior between participants that are successful at learning to regulate 
the signal and those who are unsuccessful. Half of fMRI neurofeedback studies fail to find 
participants able to regulate the target hemodynamic signal or find mixed results regarding 
regulation success and (4), and it is estimated that approximately 30% of participants will not be 
able to learn to control a signal across neurofeedback designs(13). Examination of these 
subgroups can assist in the development of subsequent randomized trials that minimize the 
number of non-learners to avoid loss of power and waste of resources by making the 
neurofeedback task more learnable and/or identifying predictors for patient selection. 
Demonstrating that regulators improve on the outcome measure relative to the unsuccessful 
regulators would allow for some conclusions regarding brain-behavior relationships to be 
established, though it is possible that the non-learners are simply unmotivated and are not 
actively engaging in the regulation strategy. However, causality cannot be established without 
appropriate control conditions. Such non-randomized studies may provide useful information 
about outcomes, for example, effect sizes of clinical improvements that can inform the sample 
calculations for definitive clinical trials. It is critical, however, that authors clearly acknowledge 
the limitations of having no control condition in their publication.  
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3. Commonly Employed Control Conditions 
Once feasibility has been established, experimental designs that focus on outcome 
evaluation are warranted. While fMRI neurofeedback may not currently be a very cost-effective 
intervention, carefully designed studies using this methodology can lead to a better 
understanding of the mechanisms underlying onset and recovery from particular disorders and 
ultimately lead to more cost-effective and directed treatments. Once a randomized clinical trial 
(RCT) is justified, the question of control intervention gains prominence. Compared to drug 
trials, for which the gold standard is the “placebo”, the options and consequently the challenges 
in the design of complex intervention trials are more numerous. Most “placebo” interventions will 
also entail an active component. 
3.1 No-Training Control  
At some point in intervention development, the comparison of neurofeedback, either as a 
stand-alone or add-on intervention, to TAU is desirable (14). This design may be particularly 
useful in scenarios where TAU is widely available and can reveal whether the neurofeedback 
component is likely to have a clinically significant benefit over available treatments. Whether 
neurofeedback has benefits over available treatments is in many respects the core clinical 
question. As fMRI neurofeedback is relatively expensive and at this time not widely available, 
the question of whether an fMRI neurofeedback intervention is effective, or an effective addition, 
to cheaper and more widely available treatments becomes crucial. The answer can inform 
decisions whether to invest in further development and evaluation of the neurofeedback 
intervention for a particular indication, or indeed whether, assuming the safety profile is 
favorable (which is currently deemed to be the case for neurofeedback (15)), to make it readily 
available as a clinical service. Of course, the neurofeedback plus TAU vs. TAU only comparison 
does not address any non-specific effects. These effects would have to be addressed by 
comparison with placebo control interventions. Furthermore, this comparison does not answer 
the question whether other interventions, for example those using cheaper biofeedback 
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technology, would have similar effects. This comparison may also be too conservative in 
settings in which TAU is already very effective and no major added benefit is expected from a 
complex intervention, which may, however, still be effective if delivered on its own. Direct 
comparison with TAU would be required to address this question. However, direct comparisons 
with TAU would realistically only be done for conditions in which TAU is either expected to be 
more expensive than neurofeedback (which may be the case for resource-intensive 
psychotherapies or for expensive proprietary drugs) or entails major side effects or compliance 
problems.     
It has been argued that because there is no true “consistent background” practice 
against which any new intervention can be tested, TAU is an inadequate control and should be 
“removed from our scientific vocabulary” (16).  Therefore, to allow for replication and 
interpretation of results, it is critical that precise details about this treatment be provided. This 
includes information about who provided the treatment, what the treatment consisted of, number 
and duration of sessions, and the country and standard of health care provided (17).  
Comparison to a wait-list control group may exaggerate the apparent efficacy of the 
intervention. For example, participants in the control group may be motivated to stay depressed 
so they are still eligible when the wait period is over (18).  
3.2 Bidirectional-Regulation Control:  
Many real-time fMRI neurofeedback studies train participants to either increase or 
decrease the mean activity level within a particular brain region or network in order to achieve a 
specific behavioral/clinical effect. Training the same participants or another group of participants 
to regulate this activity in the opposing direction should cause opposing behavioral effects, thus 
allowing for a powerful control condition. 
In neurofeedback methods development, voluntary bidirectional control of a new feedback 
signal has been used to demonstrate feasibility of that signal for training (19, 20). For example, 
before using a new connectivity signal for real-time fMRI neurofeedback training, investigators 
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tested if each participant could up- and down-regulate the connectivity signal through cognitive 
task performance (19). Whereas unidirectional control can easily be achieved through non-
specific effects such as arousal, bidirectional control is much less prone to artefactual self-
regulation (though it is possible that participants could alter breathing, muscle, or arousal levels 
both up and down to achieve bidirectional control).  
Another advantage of using bidirectional control is that it allows for ruling out motivational 
and placebo effects. Motivational differences might exist between baseline and regulation 
conditions, but not between regulating in different directions (provided that regulating the signal 
in both directions is equally feasible). Note however, that even if motivation differs between the 
different training directions (possibly because controlling in one direction is easier than the other), 
conclusions can still be drawn regarding brain-behavior relationships if the changes in behavioral 
measures from baseline in the two conditions are in opposite directions. Likewise, placebo effects 
might cause behavioral improvements (or worsening), but they cannot explain opposing 
behavioral effects as a result of bidirectional control, provided that participants are equally 
successful at regulating each direction. However, participant-bias still needs to be excluded, 
otherwise knowledge about the function of the targeted brain region (for example being trained to 
up- and down-regulating anxiety-related brain areas) might yield corresponding in-/decreases in 
anxiety. This effect could be controlled for using implicit training protocols where participants are 
unaware they are engaging in a neurofeedback task, and in some instances do not know they are 
being trained at all (see Section 4 for more detail) and careful blinding of conditions so that 
participants do not know what condition they are in, and expectations are controlled for.  
Several variants of bidirectional control exist, using either a within- or a between-group 
design, training bidirectional control of the same or of different aspects of brain function, and even 
combining bidirectional control with differential feedback. For example, in a between-group 
design, Shibata et al. trained one group to up-regulate a brain activity pattern associated with high 
facial preference, and another group to up-regulate an activity pattern associated with low facial 
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preference (21). They found that faces previously rated as neutral became more (high facial 
preference group) or less (low facial preference group) preferred. Here, bidirectional control does 
not refer to up- or down-regulating the same region of interest (ROI), but to training physiologically 
specific brain patterns to induce opposing behavior. Alternatively, Scharnowski et al. (22) used a 
within-group design to simultaneously up- and down-regulate two functionally distinct ROIs (the 
supplementary motor area (SMA) and the parahippocampal cortex (PHC)) using differential 
feedback (i.e., SMA minus PHC activity). After confirming that participants were able to up- and 
down-regulate both regions, they tested the effects of such regulation on behavioral tasks related 
to the function of the respective ROIs, i.e., a motor reaction time task related to SMA activity and 
a memory task related to PHC activity. This combination of up- and down-regulating functionally 
unrelated ROIs with ROI-specific behavioral testing allows for a strong double dissociation to 
derive specific inferences about localized brain function (23). 
Overall, bidirectional control is a powerful control condition that can be used to ensure 
physiological specificity, can control for placebo and motivational effects (provided that participant 
biases can be controlled for), and rules out non-specific effects (Table 1). This control condition 
can be used for between- as well as within-group designs, and it has been successfully used in 
biofeedback, magnetoencephalography (MEG)-, EEG-, and fMRI-neurofeedback studies (20-22, 
24-31). However, bidirectional control does not exclude that mental rehearsal alone would be 
sufficient to change brain activity and associated behavior. Another limitation is that bidirectional 
control is not always desirable, especially in clinical contexts where training the opposite direction 
might cause unwanted behavioral consequences (i.e., worsening of symptoms) in patients. This, 
however, is predominantly a precautionary measure because there is little evidence suggesting 
negative outcomes from fMRI neurofeedback training regardless of the regulation direction. 
Finally, alternating up- and down-regulation in a within-group design can induce order and carry-
over effects that can affect the behavioral outcome and might make learning more difficult (27, 
28).  
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3.3 Placebo Control 
3.3.1 Feedback of an Alternative Brain Signal: In this type of control condition, 
participants receive veritable neurofeedback, but of an aspect of brain function other than that 
targeted in the experimental group. Optimally, participants should be able to gain a similar level 
of control over the trained signal as the experimental group and any assigned mental strategy 
used should be the same across groups. This approach controls for psychoeducative effects 
(the benefit of learning to control a signal) and allows for conclusions as to whether feedback of 
the target aspect of brain function is necessary to gain control over that aspect. Additionally, this 
control condition allows for examination of whether changes in mood and behavior in the 
experimental group are due specifically to the feedback or to a placebo effect. As long as 
participants are equally successful at regulating the neurofeedback signal, motivation effects 
should also be controlled for (Table 1). For simplicity in our discussion here, we will assume a 
single brain region is trained in the experimental group, and another brain region is trained in 
the control group, although the concepts can be generalized to more complex aspects of brain 
function that are trained, such as distributed activity patterns, or functional connectivity patterns.  
When designing this type of control condition, it is important that the control ROI is 
matched to the target ROI in terms of either tissue composition, number of voxels, and/or 
temporal signal-to-noise ratio so that accurate and reliable detection of activation is possible 
and different results are not due to one region being easier to regulate because of better signal 
properties (32-34). Furthermore, the control ROI should be functionally independent from the 
target ROI (33, 34). Studies using this design can be challenging to develop as it can be difficult 
to select a control ROI that is both independent from the target ROI (so that regulating the 
control ROI does not systematically affect the target ROI’s activity), and that can be regulated 
by participants as easily as the target ROI using the same assigned mental strategy (if a mental 
strategy is assigned) (33, 35, 36). If participants are unable to regulate the control ROI, they 
may become frustrated and give up trying to regulate the signal. Then, any difference between 
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the experimental and control groups is not just due to the region regulated, but whether any 
regulation could be achieved at all. Also, if participants are unable to regulate the control ROI as 
well as the experimental group, even if they are equally motivated, they will receive less 
rewarding feedback and consequently their placebo effects may be smaller. Neurofeedback 
research using this control methodology has produced mixed results: In an fMRI-neurofeedback 
training study with children with attention deficit hyperactivity disorder (ADHD), gaining control 
over any signal (the target or control ROI) resulted in clinical improvement, suggesting it may be 
the feeling of self-efficacy or learned control over hemodynamic activity in general that leads to 
clinical improvements in individuals with this disorder (37). In adults with major depressive 
disorder, however, learning to regulate a parietal region did not result in symptom improvement, 
while learning to regulate the amygdala did (33). Several studies employing this control 
condition did not find that participants were able to learn to regulate the control ROI (34, 38, 39). 
In these studies, the effects of success, feelings of self-efficacy, and frustration cannot be ruled 
out as explaining group differences.  
When participants are equally successful at regulating the assigned ROI, this control 
condition can allow for strong conclusions, specifically that (a) information from the ROI is 
needed to gain control over that ROI and for behavioral/clinical changes to occur, and (b) 
gaining control over any signal more generally would not result in the same effects. While 
behavioral effects cannot be completely controlled for (it is still possible that engaging in the 
mental strategy only in the absence of feedback information would result in the same clinical 
and neurophysiological changes), behavioral effects are controlled for to some extent when both 
groups are instructed to use the same strategy to control a brain region. In this case, group 
differences in outcome measures are not due to engaging in the strategy while learning to 
control a signal. However, the difficulty and intense pilot testing necessary to ensure the 
selection of an appropriate control ROI make it particularly difficult to successfully implement 
this condition.  
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 3.3.2 Non-Neural Feedback: Neurofeedback is a special type of biofeedback. In 
biofeedback, a physiological measure is obtained and fed back to participants. In the case of 
neurofeedback the physiological measure is the hemodynamic response (measured with fMRI 
or fNIRS) or electrical activity (measured with EEG or MEG). Comparison of the effects of 
neurofeedback to other biofeedback methods is another type of control. As heart-rate variability 
and respiration biofeedback have been shown to reduce symptoms in patients with anxiety and 
depressive disorders (40), using this control condition has the advantage of comparing 
neurofeedback to a similar effective intervention. If subjects are equally successful at learning to 
regulate the control signal as the experimental signal, this approach can control well for 
motivation/perceived success, as well as non-specific factors (Table 1). This comparison may or 
may not control for placebo effects related to receiving a high-tech, cutting-edge intervention, 
depending on whether the subject’s perception of the experimental and control interventions is 
comparable in this respect. 
Non-neural feedback has been widely used in EEG-neurofeedback studies; but to date 
only one fMRI neurofeedback study has included it (41). In this study, autonomic tone feedback 
(including measures of skin conductance, heart rate, and respiration) associated with decreased 
arousal and increased relaxation was significantly less effective at reducing perception of pain 
than neurofeedback from the anterior cingulate cortex (41). Studies have found EEG 
neurofeedback to be superior to respiration feedback in reducing seizures in patients with 
epilepsy (42), to electromyography (EMG) feedback in reducing ADHD scores in children (43), 
and to skin-conductance feedback training in improving cognitive flexibility in autism (44). Other 
studies, however, have found EEG neurofeedback to be as effective as EMG feedback in 
reducing ADHD symptoms in children (45), and heart rate-variability training to reduce anxiety 
more than EEG-neurofeedback training in dance students (46). 
 3.3.3 Sham Feedback: In a sham control condition, participants are provided with 
feedback information that is not based on their actual brain signal. This signal can be artificially 
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(randomly or systematically) generated feedback which involves creating a signal that is not 
based on an actual brain imaging signal. Typically, the signal shares crucial properties with the 
real neurofeedback signal, including similar frequency, amplitude, and in the case of fMRI 
neurofeedback training, taking into account the hemodynamic delay (47, 48).  
 Sham feedback can also involve yoked feedback, where each control participant sees 
the actual feedback signal from a participant in the experimental group. The sham condition one 
of the most commonly employed control conditions in neurofeedback studies (36). The benefits 
of this control condition include matching the experimental condition on all aspects except 
gaining control over the experimental ROI signal. Provided that control participants do not detect 
the non-contingency between their efforts and the resulting signal change, there should be 
equal motivation and perceived success between the groups (Table 1). However, this control 
condition cannot determine if the mental strategy alone would result in similar behavioral and 
brain changes, although the same mental strategies are typically recommended to subjects in 
both groups to reduce this concern. However, when participants do detect non-contingency, 
negative effects, such as frustration and decreased motivation can become critical confounds. 
While some studies have reported that participants in yoked neurofeedback conditions did 
indeed notice the non-contingency (47, 49, 50), many studies have reported that participants 
remained unaware of this non-contingency (51-55). Unfortunately, many studies employing 
yoked feedback do not report on whether the blind was maintained or monitor frustration effects 
(47, 56-61), leaving open the possibility that the differences between the yoked and 
experimental groups were due to motivation effects and not to gaining control over the signal. 
Non-contingency is less likely to be detected in feedback studies that provide intermittent or 
delayed feedback where a summary is given after the regulation period as opposed to real-time 
feedback studies where the signal is updated continuously (e.g., every two seconds) (47). When 
employing sham feedback, monitoring frustration/satisfaction during the study, and asking 
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subjects after the study if they believe they had received the experimental intervention (and 
having them rate how confident they are in that belief) are critical for interpretation of results.  
The perception that the feedback signal is not contingent with effort will not necessarily 
differ between groups in a sham controlled study. Many participants who receive real 
neurofeedback signals do not feel that the signal changes reflect their effort (because of the 
high difficulty of controlling the signal). Thus, non-contingency with effort (and resulting 
frustration) is a common element of neurofeedback studies regardless of group assignment. 
Assuming participants are trying consistently, contingency of effort and signal change are likely 
to be similar in magnitude in the sham group and experimental neurofeedback groups (when the 
increase/decrease blocks are time-locked) because of the balancing of the perception of 
success. However, patients who are aware that sham feedback is a control condition in the 
study may be more prone to suspect non-contingency regardless of which group they were 
assigned to. This awareness may reduce overall clinical improvements that can be achieved in 
sham controlled designs.  
3.4 Mental-Rehearsal Control 
It is important to note that for all of the control conditions discussed thus far in which 
subjects are instructed to use a specific mental strategy during neurofeedback, there is 
invariably one factor that cannot be controlled for – and that is whether strategy alone would 
cause the same neural or behavioral changes. We refer to this here as a mental-rehearsal, no 
feedback, or strategy only control. Here, control subjects are instructed to self-regulate brain 
activity in the absence of any feedback information by repeatedly applying a specific self-
regulation strategy that was communicated to them before the start of the training. The mental 
strategies provided to the control subjects should be identical to those provided to participants 
receiving neurofeedback information prior to the start of training. These strategies should be 
guided by theoretical considerations and empirical evidence from literature, as well as on the 
experience of study participants who have undergone the neurofeedback task. The selected 
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mental strategy must be clear and unambiguous and should be provided in written form to 
participants. It is also advisable to verify participants that understand the mental strategy to be 
used. 
Within a sample of 99 studies systematically analyzed in a recent literature review on 
fMRI-neurofeedback experiments (4), 17 studies employed this control condition. This control 
condition has been often criticized due to its differences in terms of expectation and motivation 
when compared to the neurofeedback situation. However, the mental-rehearsal control holds 
several crucial advantages and can play a critical role in demonstrating a true neurofeedback 
effect because it provides the only possibility to control for the effects of simply engaging in the 
behavioral/cognitive strategy without the help of any additional (e.g., neurofeedback) 
information. Additionally, in specific situations, mental rehearsal constitutes the only meaningful 
control condition (e.g. in communication and control brain-computer interface (BCI) studies that 
involve a neurofeedback approach or when investigating the neural correlates and mechanisms 
of fMRI-neurofeedback(62, 63)). For example, Sorger and colleagues (62) investigated whether 
varying the loudness of inner speech (a mental-strategy control) aids in gradual brain-activity 
regulation. The researchers tested both whether the gradual modulation ability was pre-given 
(no-feedback condition/mental task performance only) or could be further enhanced by 
providing participants with continuous feedback about the current brain-activity level in a mental-
task-specific brain region (feedback condition). To include a sham-feedback condition in this 
instance would not have been a meaningful option as sham feedback is not expected to further 
increase the gradual modulation ability. Of course, it might still be possible that sham 
neurofeedback could motivate participants to try harder and in turn help them alter the behavior 
in question in a gradual manner.  
Generally, the mental-rehearsal control condition can be easily applied, as its 
implementation is technically less challenging than the implementation of any placebo control 
condition. Moreover, this control condition does not suffer from the ethical limitations that might 
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emerge in placebo feedback control conditions (see discussion in section 3.5). While the 
mental-rehearsal control condition can be used both in within- and between-group designs, the 
latter should be preferred to prevent undesirable order and carry-over effects (see, e.g., 62). 
Mental-rehearsal can be employed as control condition for both continuous- and intermittent-
neurofeedback designs. Compared with intermittent neurofeedback, mental rehearsal is 
considerably easier to match to the neurofeedback condition in terms of sensory input and the 
levels of cognitive demand/work load.  
The mental-rehearsal control condition can be implemented both inside (57, 59, 60, 62-
80) and outside the MRI scanner (e.g., 41, 81, 82-84). The latter option is much easier to realize 
and considerably decreases associated (personnel and scanning) costs. For this reason, mental 
rehearsal might provide a more economical solution in case of limited resources. However, 
implementing this control condition inside the MRI scanner has several advantages: global, 
spatially non-specific (e.g., general-arousal) effects can be ruled out later by analyzing the 
functional brain-imaging data that is obtained during mental rehearsal; and placebo and 
motivational effects can be partially controlled for because participants are placed in the same 
high-tech MRI environment (though not experiencing the neurofeedback setup). Another 
possibility to control/reduce motivational effects related to the MRI environment itself might be to 
implement the mental-rehearsal control condition in a dummy (or ‘mock’) scanner. It might be 
challenging to make participants believe that they are in a true MRI scanning environment but it 
would allow matching at least a few additional factors. Global motivational effects can be further 
limited when control subjects are not informed about the existence of the neurofeedback group, 
as awareness that one does not belong to the main experimental group might considerably 
lower a participant’s motivation. Instead, participants might be told that they are participating in 
a training study applying a specific mental strategy in which brain activity will be measured at 
the same time in order to trace the training effect in the brain (see discussion in 79, 80). 
Frustration is a potential confound even when receiving veritable feedback, in case of failure to 
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control the neurofeedback signal. Participants in the mental-rehearsal control condition, 
however, are less likely to be frustrated as they do not expect nor receive any information on 
their current performance. On the other hand, they may have reduced motivation compared to 
the experimental group because the feedback is generally engaging and they are not receiving 
any. 
Despite many features, using the mental-rehearsal control condition alone is not 
sufficient to exclude all possible alternative explanations for an obtained positive behavioral 
neurofeedback effect. Most importantly, mental rehearsal cannot rule out motivational and 
placebo effects as this control condition does not include the feedback component. While this 
control condition is helpful in establishing a true neurofeedback effect by controlling for pure 
behavioral effects, mental rehearsal should ideally be combined with one or more other control 
conditions (see Table 1), either in the same or consecutive studies. 
3.5 Practical Implementation 
3.5.1 What to Disclose to Participants: One issue that is particularly important in the 
context of control conditions is the degree of disclosure to participants regarding the study 
design. If participants are told that there is a sham feedback group, it can make them more likely 
to look for a mismatch between the feedback signal and what they expect the brain region to be 
doing, and thus can make them more likely to guess that they are not getting veritable 
neurofeedback. This issue must also be considered with alternative ROI controls. For example, 
if the goal is to treat anxiety symptoms and participants are told that they will either be trained 
on an anxiety-related brain region or a region unrelated to anxiety, control participants may be 
more likely to notice if the feedback does not match their anxiety and to suspect they are getting 
the control intervention. Having figured out their group allocation, it is possible that these 
participants will assume that their symptoms could not have improved and this assumption may 
influence the behavioral effects. In some clinical trials, vagueness is used and participants are 
simply told that there are two conditions they can be assigned to randomly (an experimental 
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intervention that may improve symptoms and a control intervention that is not expected to 
improve symptoms) but not about the precise difference between these two conditions. Non-
authorized deception, where participants are not told of the existence of a control condition until 
after completion of the study (as opposed to authorized deception where researchers inform 
participants beforehand that deception will be used, but not how), may be an acceptable option, 
provided that participants are then offered the experimental intervention following completion of 
the study protocol. How much researchers are required to disclose to participants probably 
varies across different institutions, depending on the particular legal environment and 
requirements from the institutional review board (IRB), and may affect what the best control 
option is for a given group.  
3.5.2 Ethical Concerns: Research using sham or alternative ROI feedback has raised 
ethical concerns for researchers (36, 85-87). One concern is that researchers are withholding 
effective treatment, violating the conditions set forth in the declaration of Helsinki(88). 
Neurofeedback, however, has yet to achieve the status of “evidence-based medicine” and 
therefore controlled studies are not withholding established effective treatment (89). Indeed, the 
goal of many of these studies is to determine whether neurofeedback might be developed into 
an effective treatment. Furthermore, researchers could administer experimental neurofeedback 
to all participants after completion of the experiment to ensure that all participants eventually 
received the investigational treatment (88), as is common procedure in pharmacological clinical 
trials.  
4. Special Case: Implicit Neurofeedback  
The choice of a control condition not only depends on what aspect one wants to control 
for, but also on the experimental neurofeedback approach itself. To date, most fMRI 
neurofeedback training studies have followed an explicit approach where participants are 
informed about the neurofeedback target region(s) and potential regulation strategies. In contrast, 
implicit neurofeedback is characterized by training participants without providing them with any 
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information regarding the trained brain region, what the feedback signal represents, or potential 
mental strategies (90). In fMRI neurofeedback, this approach is often characterized by training 
participants to match ongoing brain activity to a multivariate brain activity pattern that is associated 
with a specific behavior, mental, or perceptual state (coined “Decoded Neurofeedback” or 
‘DecNef’ (91)), but may also be applied when following the more classical neurofeedback 
approach of changing the mean activity level within a particular brain region or connectivity 
measure of a network. It is difficult to run a mental-rehearsal control group with this paradigm, 
because the experimental group is not provided with strategy suggestions, and debriefing of 
participants that have been trained with implicit neurofeedback indicate diverse mental activities 
that often seem unrelated to the brain activity pattern that was trained (21).  
Instead of including a mental-rehearsal control group, in certain implicit neurofeedback 
paradigms, one can make sure that behavioral effects are primarily due to neurofeedback by 
training only one specific brain state, e.g., a visual-cortex activity pattern corresponding to a 70 
degree grating orientation, and testing visual sensitivity for gratings of different orientations. Using 
this approach, Shibata et al. found improved visual sensitivity only for the trained grating 
orientation but not for other grating orientations, thus ensuring physiological specificity of the 
behavioral effect (91). In this way, placebo, non-specific and motivation effects can also be 
excluded, because these effects are not specific to only the target grating orientation which is 
unknown to the participants. Another example comes from Koizumi et al., in which participants 
were reinforced when their brain activity reflected a pattern in the visual cortex associated with a 
fearful stimulus in the absence of stimulus presentation (92). This training reduced the fear 
response (measured by skin conductance response) to the trained conditioned stimulus (i.e., 
green circle) but not to untrained but conditioned stimuli (i.e., red circle). In this example, there is 
no control condition per se, but instead there is a control outcome measure – ensuring the 
specificity of the effects by demonstrating that only the targeted behavior has changed.  
5. Discussion 
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There are numerous options for control conditions in neurofeedback studies, and there is 
no single best control condition that addresses all potential confounding factors. This conclusion 
may lead researchers to believe that they need to include all of the control conditions discussed 
into a single study. However, this approach would be very elaborate and costly and therefore 
not realistic considering limited resources and the negative effects of multiple-group designs on 
power. The most comprehensive study to date employed five different control conditions 
including behavioral training only (mental rehearsal), twice the amount of behavioral training as 
neurofeedback training, alternative ROI feedback, yoked feedback, and autonomic 
biofeedback(41). Only participants in the experimental group receiving anterior cingulate 
neurofeedback reported decreased perception of pain, leading the authors to conclude that it is 
gaining control of a particular regional signal that leads to the observed changes in pain 
perception, and not effects of motivation, expectation, or non-specific effects. Unfortunately, the 
sample was very small (only 4-8 participants in each group) and the authors were unable to 
replicate their results (89). Thus, ensuring properly powered studies is also an important 
consideration when designing neurofeedback studies.  
The trade-off between maximizing power and controlling for all possible confounds is 
one of the challenges of neurofeedback study design. As explained in Button et al (2013)(93), 
adequately powered studies are needed to ensure reproducibility of results. However, even 
assuming a large effect size of d=0.8, a study contrasting the experimental group with a single 
control group requires 26 subjects per group to have an 80% chance of detecting an effect at a 
p<0.05 level with a 2-tailed t-test. Thus, it is challenging for researchers to run fully powered 
neurofeedback studies even with a single control group, and running a well powered study 
involving more than one control group is not always feasible, particularly when the group studied 
is difficult to recruit (as is often the case in clinical studies involving patient populations). 
Several neurofeedback studies training healthy participants have implemented a dual-
control design where the experimental neurofeedback condition is compared to sham/alternative 
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ROI feedback and a separate mental-rehearsal group. For example, neurofeedback from the 
insula has been found to result in increased insula activity compared to alternative ROI 
feedback and engaging in the identical strategy in the fMRI environment as during experimental 
neurofeedback (57). Furthermore, participants receiving rostrolateral prefrontal cortex 
neurofeedback were able to significantly increase activity in this region relative to participants 
receiving yoked feedback or doing mental rehearsal in the fMRI environment (59). By using 
these two control conditions, these studies were able to demonstrate physiological specificity 
(feedback from the region is needed to regulate that region) and to rule out placebo, motivation, 
and non-specific effects (as the yoked or alternative ROI feedback group had the same 
expectations and experience of success as the experimental neurofeedback group) and to 
establish that simply engaging in the strategy in the absence of neurofeedback would not result 
in similar neurophysiological changes. 
A more common approach, particularly in clinical populations, is to use one control group 
that receives a placebo-controlled form of feedback and is also matched for the instructed or 
suggested mental strategies to try during feedback (33, 54, 94). By minimizing the number of 
control groups, this approach aims to maximize power while still controlling both for the 
assigned mental strategy and placebo/motivation effects. How precisely the mental tasks are 
controlled for may vary, depending on whether the mental strategies are instructed, or just 
recommended, on whether there are multiple strategies allowed, and on how well-defined and 
uniformly executed the mental strategies are.  
The focus of this paper has been on control conditions for real-time fMRI neurofeedback 
studies. However, neurofeedback is also being done using EEG, MEG, and fNIRS. Many of the 
issues we discuss herein apply to neurofeedback studies in general, regardless of the functional 
imaging technique being implemented. Sham neurofeedback, for example, is possible across all 
of these techniques. Instead of an alternative region as a control condition, different frequency 
bands or locations (e.g., anterior vs. posterior alpha) can be used. EEG neurofeedback has 
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been in place for decades (e.g., (95, 96) for a review). MEG and fNIRS neurofeedback are still 
in the early phases of development and testing, with many studies identifying as pilot studies 
that do not include any control condition(20, 97-99), though some have included a sham 
feedback control (48, 100, 101), or more complex designs (102).  
Finally, we note that it is critical to address the issue of control between studies. fMRI 
protocols have been notoriously difficult to replicate and there is a ‘replication crisis’ in the field 
of neuroimaging(103). The field would benefit greatly from pre-registering experiments and 
standardizing measures, design, statistical analysis, and reporting. A review of current best 
practices for neurofeedback designs can be found in (4).  
In conclusion, the best approach to designing neurofeedback studies should enable the 
exclusion of as many potential confounds/alternative effects as possible. In many cases, multiple 
control conditions will be ideal, but whether the target neurofeedback intervention should be 
compared with multiple control conditions in one study, or consecutively over different studies is 
a matter of study design that has to take power, resources, and scientific and clinical priorities 
into consideration. Input from clinical trial experts and statisticians will be crucial in this process. 
The specific goal of a particular neurofeedback study can help inform the choice of a control 
condition; if the goal is to determine clinical efficacy in patients, comparison to TAU or sham 
neurofeedback may be appropriate. If the goal, however, is to understand brain-behavior 
relationships in healthy individuals, bidirectional, alternative ROI, or sham may be the best choice.   
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Figure Captions 
 
Figure 1: Overview of control conditions for neurofeedback studies 
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Table 1: Explicit Control Conditions Commonly Employed in Neurofeedback Studies and the Confounding Factors they Address.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 * if ability to control is balanced across groups 
^ if subjects are not unblinded by signal not matching mental changes 
@ if control signal does not have an antagonistic relationship with the behavioral/clinical variable of interest. 
+ signifies a situation in a clinical context. 
  No-training Control  Placebo Control Mental-Rehearsal Control 
Factors to be 
controlled for to 
establish causality 
No control 
Treatment 
as usual+ 
List of 
matched 
participants/ 
Waitlist+ 
Bidirectional-
Regulation 
Control 
Alternative feedback Sham feedback 
Inside the MRI 
scanner 
Outside the MRI 
scanner 
     
Feedback from an 
Alternative Brain 
Signal 
Feedback 
based on non-
brain signals 
‘Yoked’ 
feedback 
Artificially 
generated 
feedback 
Equal Motivation/ 
Perception of 
Success  
 
   
        
  
Demonstrate 
neurophysiological 
specificity 
 
   
  
     
Exclude 
placebo effects 
    
     
  
Exclude 
global (spatially 
non-specific) 
effects 
 
   
      
 
Exclude 
Behavioral effects 
         
  
Remarks 
Extremely 
economical 
Economical 
 
Crucial (and 
fairest) 
control 
group in 
clinical 
context 
Very 
economical 
Up- and 
downregulati
on of the 
same region 
might not 
always be 
possible 
 
Not always 
ethically 
justifiable+ 
Regions’ signal 
properties 
should be 
matched across 
groups 
 
Might be too 
conservative 
(critical region 
might be trained 
via functional 
connectivity) 
 
Risk of 
unblinding 
participants 
Risk of 
unblinding 
participants 
Risk of 
unblinding 
participants 
Should be 
generated 
considering 
properties of 
the 
hemodynami
c response 
 
Risk of 
unblinding 
participants 
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(implicit 
neurofeedback) 
 
Control 
participants 
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aware of the 
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neurofeedback 
group 
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neurofeedback) 
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minimize 
scanning costs 
 
Control 
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aware of the 
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neurofeedback 
group 
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